2013 Therapeutic Drug Monitoring (TDM) Market in Japan: Hospitals and Commercial Labs:Life Sciences Market Research Reports

Life Sciences Market Research Reports

2013 Therapeutic Drug Monitoring (TDM) Market in Japan: Hospitals and Commercial Labs Apr 4th 2013, 00:00 This new provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin. During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99746. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/2013-therapeutic-drug-monitoring-tdm-market-in-japan-hospitals-and-commercial-labs-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions